Impaired energy metabolism of the taurine-deficient heart

详细信息    查看全文

• 作者：Stephen W. Schaffer ; Kayoko Shimada-Takaura ; Chian Ju Jong ; Takashi Ito…
• 关键词：Taurine ; Respiratory chain ; Palmitate metabolism ; Glucose oxidation ; ATP production ; MELAS
• 刊名：Amino Acids
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：48
• 期：2
• 页码：549-558
• 全文大小：884 KB
• 参考文献：Arakawa K, Kudo T, Ikawa M, Morikawa N, Kawai Y, Shashi K, Lee J-D, Kuriaya M, Miyamori I, Okazawa H, Makoto Y (2010) Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to l -arginine infusion: C-11 acetate kinetics revealed by positron emission tomography. Circ J 74:2702–2711CrossRef PubMed
  Azuma J, Swanamura A, Awata N (1992) Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J 56:95–99CrossRef PubMed
  Barger PM, Kelly DP (2001) PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 10:238–245CrossRef
  Bartlett K, Eaton S (2004) Mitochondrial beta-oxidation. Eur J Biochem 271:4462–4469CrossRef
  Campbell FM, Kozak R, Wagner A, Altarejos JY, Dyck JRB, Belke DD, Severson DL, Kelly DP, Lopaschuk GD (2002) A role for peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the control of cardiac malonyl CoA levels. J Biol Chem 277:40098–44103CrossRef
  Chapman RA, Suleiman M-S, Earm YE (1993) Taurine and the heart. Cardiovasc Res 27:358–363CrossRef PubMed
  Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ (2003) Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278:36927–36931
  Gabriel JL, Plaut GW (1984) Inhibition of bovine heart NAD-specific isocitrate dehydrogenase by reduced pyridine nucleotides: modulation of inhibition by ADP, NAD+, Ca2+, citrate, and isocitrate. Biochemistry 23:2773–2778CrossRef PubMed
  Gajewski CD, Yang L, Schon EA, Manfredi G (2003) New insights into the bioenergetics of mitochondrial disorders using intracellular ATP reporters. Mol Biol Cell 14:3628–3635CrossRef PubMed PubMedCentral
  Ingwall JS, Weiss RG (2004) Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95:135–145CrossRef PubMed
  Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927–937CrossRef PubMed
  James AM, Wei Y-H, Pang C-Y, Murphy MP (1996) Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem J 318:401–407CrossRef PubMed PubMedCentral
  James AM, Sheard PW, Wei Y-H, Murphy MP (1999) Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations: implications for neurodegenerative and mitochondrial diseases. Eur J Biochem 259:462–469CrossRef PubMed
  Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD (2011) targeting fatty acid and carbohydrate oxidation: a novel therapeutic intervention in the ischemic and failing heart. Biochem Biophys Acta 1813:1333–1350CrossRef PubMed
  Jong CJ, Azuma J, Schaffer S (2012) Mechanism underling the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids 42:2223–2232CrossRef PubMed
  Kami K, Fujita Y, Igarashi S, Koike S, Sugawara S, Ikeda S, Sato N, Ito M, Tanaka M, Tomita M, Soga T (2012) Metabolomic profiling rationalized pyruvate efficacy in cybrid cells harboring MELAS mitochondrial DNA mutations. Mitochondrion 12:644–653CrossRef PubMed
  Kirino Y, Yasukawa T, Ohta S, Akira S, Ishihara K, Watanabe K, Suzuki T (2004) Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc Natl Acad Sci 101:15070–15075CrossRef PubMed PubMedCentral
  Kramer JH, Lampson WG, Schaffer SW (1983) Effect of tolbutamide on myocardial energy metabolism. Am J Physiol 245:H313–H319PubMed
  Krebs HA, Eggleston LV (1948) Metabolism of acetoacetate in animal tissues. Biochem J 42:294–305CrossRef PubMedCentral
  Lawlis VB, Roche TE (1981) Inhibition of bovine kidney alpha-ketoglutarate dehydrogenase complex by reduced nicotinamide adenine dinucleotide in the presence or absence of calcium ion and effect of adenosine 5′-diphosphate on reduced nicotinamide adenine dinucleotide inhibition. Biochemistry 20:2519–2524CrossRef PubMed
  Pion PD, Kittleson MD, Rogers QR, Morris JG (1987) Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764–768CrossRef PubMed
  Ramila KC, Jong CJ, Pastukh V, Ito T, Azuma J, Schaffer SW (2015) Role of protein phosphorylation in excitation–contraction coupling in taurine deficient hearts. Am J Physiol 308:H232–H239
  Rosca MG, Hoppel CL (2010) Mitochondria in heart failure. Cardiovasc Res 88:40–50CrossRef PubMed PubMedCentral
  Schaffer SW, Tan BH, Wilson GL (1985) Development of a cardiomyopathy in a model of noninsulin-dependent diabetes. Am J Physiol 248:H179–H185PubMed
  Schaffer SW, Seyed-Mozaffari M, Cutcliff CR, Wilson GL (1986) Postreceptor myocardial metabolic defect in a rat model of non-insulin-dependent diabetes mellitus. Diabetes 55:593–597CrossRef
  Schaffer SW, Solodushko V, Kakhniashvili D (2002) Beneficial effect of taurine depletion on osmotic, sodium and calcium loading. Am J Physiol 282:C1113–C1120CrossRef
  Schaffer SW, Jong CJ, Ito T, Azuma J (2014a) Effect of taurine on ischemia-reperfusion injury. Amino Acids 46:21–30CrossRef PubMed
  Schaffer SW, Jong CJ, Ito T, Azuma J (2014b) Role of taurine in the pathologies of MELAS and MERRF. Amino Acids 46:47–56CrossRef PubMed
  Stanley WC, Recchia FA, Lopaschuk GD (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85:1093–1129CrossRef PubMed
  Suleiman MS (1994) New concepts in the cardioprotective action of magnesium and taurine during the calcium paradox and ischaemia of the heart. Magnes Res 7:295–312PubMed
  Suzuki T, Wada T, Saigo K, Watanabe K (2002) Taurine as a constituent of mitochondrial tRNAs: new insight into the functions of taurine and human mitochondrial diseases. EMBO J 21:6581–6589CrossRef PubMed PubMedCentral
  Thurston JH, Hauhart RE, Naccarato EF (1981) Taurine: possible role of osmotic regulation of mammalian heart. Science 214:1373–1374CrossRef PubMed
  Ventura-Clapier R, Garnier A, Beksler V, Joubert F (2011) Bioenergetics of the failing heart. Biochim Biophys Acta 1813:1360–1372CrossRef PubMed
  Wan B, LaNoue KF, Cheung JY, Scaduto RC Jr (1989) Regulation of citric acid cycle by calcium. J Biol Chem 264:13430–13439PubMed
  Weitzman PDJ, Dunmore P (1969) Citrate synthases: allosteric regulation and molecular size. Biochem Biophys Acta 171:198–200PubMed
  
• 作者单位：Stephen W. Schaffer (1)
  Kayoko Shimada-Takaura (1)
  Chian Ju Jong (1)
  Takashi Ito (2)
  Kyoko Takahashi (3)
  
  1. Department of Pharmacology, University of South Alabama College of Medicine, Mobile, AL, 36688, USA
  2. School of Pharmacy, Hyogo University of Health Sciences, Kobe, Japan
  3. Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Life Sciences
  Biochemistry
  Analytical Chemistry
  Biochemical Engineering
  Life Sciences
  Proteomics
  Neurobiology
  
• 出版者：Springer Wien
• ISSN：1438-2199

文摘

Taurine is a β-amino acid found in high concentrations in excitable tissues, including the heart. A significant reduction in myocardial taurine content leads to the development of a unique dilated, atrophic cardiomyopathy. One of the major functions of taurine in the heart is the regulation of the respiratory chain. Hence, we tested the hypothesis that taurine deficiency-mediated defects in respiratory chain function lead to impaired energy metabolism and reduced ATP generation. We found that while the rate of glycolysis was significantly enhanced in the taurine-deficient heart, glucose oxidation was diminished. The major site of reduced glucose oxidation was pyruvate dehydrogenase, an enzyme whose activity is reduced by the increase in the NADH/NAD+ ratio and by decreased availability of pyruvate for oxidation to acetyl CoA and changes in [Mg2+]_i. Also diminished in the taurine-deficient heart was the oxidation of two other precursors of acetyl CoA, endogenous fatty acids and exogenous acetate. In the taurine-deficient heart, impaired citric acid cycle activity decreased both acetate oxidation and endogenous fatty acid oxidation, but reductions in the activity of the mitochondrial transporter, carnitine palmitoyl transferase, appeared to also contribute to the reduction in fatty acid oxidation. These changes diminished the rate of ATP production, causing a decline in the phosphocreatine/ATP ratio, a sign of reduced energy status. The findings support the hypothesis that the taurine-deficient heart is energy starved primarily because of impaired respiratory chain function, an increase in the NADH/NAD+ ratio and diminished long chain fatty acid uptake by the mitochondria. The results suggest that improved energy metabolism contributes to the beneficial effect of taurine therapy in patients suffering from heart failure.